Davenport & CO LLC Merck & Co., Inc. Call Options Transaction History

Davenport & CO LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Jan 24, 2025	BUY	$96.31 - $114.76 $510,443 - $608,228	5,300 Added 68.83%	13,000 $1.29 Million
Q3 2024 Oct 24, 2024	BUY	$111.15 - $128.97 $855,855 - $993,069	7,700 New	7,700 $874,000
Q4 2023 Jan 23, 2024	SELL	$100.18 - $109.02 $10,018 - $10,902	-100 Reduced 4.55%	2,100 $228,000
Q3 2023 Oct 17, 2023	BUY	$102.95 - $114.33 $10,295 - $11,433	100 Added 4.76%	2,200 $226,000
Q1 2023 Apr 27, 2023	SELL	$102.94 - $114.86 $154,410 - $172,290	-1,500 Reduced 41.67%	2,100 $223,000
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $1.36 Million - $1.74 Million	-15,500 Reduced 81.15%	3,600 $0
Q2 2022 Jul 18, 2022	SELL	$83.49 - $94.64 $100,188 - $113,568	-1,200 Reduced 5.91%	19,100 $1.74 Million
Q1 2022 May 02, 2022	BUY	$73.51 - $82.4 $14,702 - $16,480	200 Added 1.0%	20,300 $1.67 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $1.45 Million - $1.82 Million	20,100 New	20,100 $1.54 Million

3,816

1.86B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.